Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Raymond James Financial
RJF
$34.8B
| $22.2M | 0.01% |
348,477
-288,065
| -45% | -$16.5M |
|
1602
Rigel Pharmaceuticals
RIGL
$795M
| $22.2M | 0.01% |
633,981
+7,905
| +1% | +$229K |
|
1603
Cousins Properties
CUZ
$4.89B
| $22.2M | 0.01% |
662,284
-880,057
| -57% | -$27.2M |
|
1604
PUT
StoneCo
STNE
$2.32B
| $22.2M | 0.01% |
264,200
+27,500
| +12% | +$1.84M |
|
1605
Wintrust Financial
WTFC
$11B
| $22.1M | 0.01% |
362,564
-125,246
| -26% | -$6.74M |
|
1606
CALL
Vanguard S&P 500 ETF
VOO
$1.04T
| $22.1M | 0.01% |
64,400
-3,600
| -5% | -$1.17M |
|
1607
CALL
Duke Energy
DUK
$96.6B
| $22.1M | 0.01% |
241,500
-270,400
| -53% | -$25M |
|
1608
SEI Investments
SEIC
$12.8B
| $22.1M | 0.01% |
384,720
+55,016
| +17% | +$3M |
|
1609
PUT
Virgin Galactic
SPCE
$503M
| $22.1M | 0.01% |
46,585
-9,505
| -17% | -$4.44M |
|
1610
Universal Health Services
UHS
$10B
| $22.1M | 0.01% |
160,709
+135,513
| +538% | +$16.9M |
|
1611
CALL
State Street SPDR S&P Retail ETF
XRT
$640M
| $22.1M | 0.01% |
343,500
+96,300
| +39% | +$5.52M |
|
1612
Steven Madden
SHOO
$3.45B
| $22.1M | 0.01% |
624,773
-209,484
| -25% | -$5.96M |
|
1613
CALL
GDS Holdings
GDS
$6.89B
| $22.1M | 0.01% |
235,600
+22,600
| +11% | +$2.01M |
|
|
MMP
1614
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $22M | 0.01% |
518,500
+110,600
| +27% | +$4.41M |
|
1615
CNX Resources
CNX
$5.28B
| $21.9M | 0.01% |
2,028,722
-4,817,860
| -70% | -$48.6M |
|
1616
Plug Power
PLUG
$3.24B
| $21.9M | 0.01% |
646,084
-1,139,400
| -64% | -$25.8M |
|
1617
Murphy USA
MUSA
$10.5B
| $21.9M | 0.01% |
167,336
-152,615
| -48% | -$19.6M |
|
1618
Lamb Weston
LW
$7.3B
| $21.9M | 0.01% |
277,660
+66,434
| +31% | +$4.84M |
|
|
WBT
1619
DELISTED
Welbilt, Inc.
WBT
| $21.8M | 0.01% |
1,650,233
-230,665
| -12% | -$2.07M |
|
1620
CALL
Southern Company
SO
$107B
| $21.8M | 0.01% |
354,500
-387,500
| -52% | -$23.3M |
|
1621
PUT
Hilton Worldwide
HLT
$73.6B
| $21.8M | 0.01% |
195,700
-140,800
| -42% | -$13.9M |
|
1622
PUT
Nucor
NUE
$61B
| $21.8M | 0.01% |
409,100
-24,600
| -6% | -$1.27M |
|
1623
BioNTech
BNTX
$23.4B
| $21.7M | 0.01% |
266,738
+124,192
| +87% | +$12.2M |
|
1624
Teck Resources
TECK
$31.2B
| $21.7M | 0.01% |
1,197,805
-4,743,319
| -80% | -$73.1M |
|
1625
PUT
Ball Corp
BALL
$16.4B
| $21.7M | 0.01% |
233,200
-70,400
| -23% | -$6.51M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.